Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sanofi - American Depositary Shares
(NQ:
SNY
)
51.68
+0.82 (+1.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sanofi - American Depositary Shares
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
34
35
Next >
Sanofi Scores A Big Beat As Dupixent Snags The Spotlight, Again
April 28, 2022
Dupixent sales rocketed higher in the quarter, driven by continued uptake in eczema treatment.
Via
Investor's Business Daily
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
April 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Microsoft Gives Glimpse Of Xbox Cloud Gaming Numbers
April 27, 2022
Microsoft Corporation (NASDAQ: MSFT) CEO Satya Nadella said Tuesday that more than 10 million people have streamed games on its Xbox Cloud Gaming platform. What Happened: Nadella...
Via
Benzinga
This Digital Healthcare Company Is Reporting Multiple New Contracts That It Hopes Might Take It To New Levels
April 26, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The year may have kicked off with a...
Via
Benzinga
Why Did Truist Lower IGM Biosciences' Price Target?
March 30, 2022
Via
Benzinga
Why Is IGM Biosciences (IGMS) Stock Up Today?
March 29, 2022
Here are the various catalysts investors in IGM Biosciences and IGMS stock are watching today as shares more than double.
Via
InvestorPlace
Earnings Scheduled For April 28, 2022
April 28, 2022
Companies Reporting Before The Bell • PBF Energy (NYSE:PBF) is projected to report quarterly earnings at $0.26 per share on revenue of $8.24 billion.
Via
Benzinga
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
April 25, 2022
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...
Via
Benzinga
Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran
April 25, 2022
Terran Biosciences is slowly but surely finding its place in the psychedelics industry.
Via
Benzinga
Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ
April 22, 2022
Via
Benzinga
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns.
Via
InvestorPlace
How To Attend Sanofi Q1 2022 Earnings Conference Call
April 19, 2022
Sanofi (NASDAQ:SNY) will host a conference call at 08:30 AM ET on April 28, 2022, to discuss Q1 2022 earnings results.
Via
Benzinga
As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
April 18, 2022
In the latest phase of the COVID-19 pandemic, federal and local officials are leaving it up to people to assess if they need booster shots, whether to wear a mask and how long to isolate after a...
Via
Benzinga
Sanofi's Rilzabrutinib Data In Autoimmune Blood Disorder Published In New England Journal of Medicine
April 14, 2022
Via
Benzinga
Cognitive Drugs Market Expected Reach Revenues Of $21 Billion in 2027
April 13, 2022
Palm Beach, FL – April 13, 2022 – FinancialNewsMedia.com News Commentary – Dementia is the loss of cognitive functioning, thinking, remembering, reasoning, and behavioral abilities to such an extent...
Via
FinancialNewsMedia
Exposures
COVID-19
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
April 11, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Friday Stocks Update
April 08, 2022
Royal Dutch Shell rose again on its earnings but is still at a p/e ratio of under 11x earnings.
Via
Talk Markets
What Is RSV, And Why Is Pfizer Paying Up To $525M For Treatment Candidates?
April 07, 2022
Pharma giant Pfizer, Inc. (NYSE: PFE), which has found huge success with its COVID franchise, is now looking to conquer another frontier.
Via
Benzinga
The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More
April 07, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high...
Via
Benzinga
Europe Approves Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6-11 Years With Type 2 Inflammation
April 07, 2022
The
Via
Benzinga
Biden To Propose Change To Obamacare To Extend Subsidies For Families: WSJ
April 05, 2022
Via
Benzinga
Sanofi To List Drug Ingredient Spin-Off EUROAPI On Euronext Paris in May
April 01, 2022
Sanofi SA (NASDAQ: SNY) plans to list its drug ingredients subsidiary EUROAPI on May 6, saying the business is set to grow and improve its profitability as a separate business.
Via
Benzinga
House Passes Bill To Cap Out-of-Pocket Insulin Costs To No More Than $35/Month
April 01, 2022
The House of Representatives voted to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare.
Via
Benzinga
EMA Starts Review Of Sanofi-GlaxoSmithKline's COVID-19 Vaccine
March 30, 2022
Via
Benzinga
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
March 30, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Mid-Afternoon Market Update: Dow Surges 250 Points; NeoGenomics Shares Slide
March 29, 2022
U.S. stocks traded higher toward the end of trading, with the Dow jumping over 250 points on Tuesday.
Via
Benzinga
Biden Administration Proposes $82B In Spending For Future Pandemics Preparedness
March 29, 2022
President Biden's budget proposal calls for $81.7 billion to spend over five years preparing for future pandemics, which would be a significant investment in boosting the country
Via
Benzinga
53 Biggest Movers From Yesterday
March 30, 2022
Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...
Via
Benzinga
Mid-Day Market Update: Crude Oil Down 2.5%; IGM Biosciences Shares Jump
March 29, 2022
U.S. stocks traded higher midway through trading, with the Dow jumping over 250 points on Tuesday.
Via
Benzinga
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
34
35
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.